Little House Capital LLC Has $587,000 Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Little House Capital LLC decreased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,512 shares of the company’s stock after selling 198 shares during the period. Little House Capital LLC’s holdings in GE HealthCare Technologies were worth $587,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in the company. D1 Capital Partners L.P. acquired a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at $268,159,000. Van ECK Associates Corp lifted its position in shares of GE HealthCare Technologies by 107.3% during the 4th quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company’s stock worth $378,520,000 after buying an additional 2,506,417 shares during the last quarter. State Street Corp boosted its stake in GE HealthCare Technologies by 7.8% in the third quarter. State Street Corp now owns 18,615,890 shares of the company’s stock valued at $1,747,101,000 after buying an additional 1,347,114 shares in the last quarter. Massachusetts Financial Services Co. MA bought a new position in GE HealthCare Technologies in the third quarter valued at about $93,713,000. Finally, Jennison Associates LLC lifted its holdings in shares of GE HealthCare Technologies by 124.5% in the fourth quarter. Jennison Associates LLC now owns 1,709,635 shares of the company’s stock worth $133,659,000 after acquiring an additional 948,017 shares during the last quarter. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Trading Down 1.4 %

NASDAQ GEHC opened at $92.21 on Friday. GE HealthCare Technologies Inc. has a 12 month low of $74.51 and a 12 month high of $94.80. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The firm has a market capitalization of $42.13 billion, a PE ratio of 25.33, a price-to-earnings-growth ratio of 2.93 and a beta of 1.15. The business’s 50-day moving average price is $84.03 and its two-hundred day moving average price is $85.53.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The business had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. On average, analysts expect that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 14th were paid a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.15%. The ex-dividend date was Tuesday, January 14th. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.85%.

Analyst Ratings Changes

Several brokerages recently issued reports on GEHC. Citigroup lifted their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their target price for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, Wells Fargo & Company increased their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $97.67.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.